HealthInvest Partners AB as of Dec. 31, 2022
Portfolio Holdings for HealthInvest Partners AB
HealthInvest Partners AB holds 53 positions in its portfolio as reported in the December 2022 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Utah Medical Products (UTMD) | 18.2 | $9.4M | 94k | 100.53 | |
| Cardinal Health (CAH) | 14.8 | $7.7M | 100k | 76.87 | |
| Cigna Corp (CI) | 10.2 | $5.3M | 16k | 331.34 | |
| Viatris (VTRS) | 10.2 | $5.3M | 475k | 11.13 | |
| GSK Sponsored Adr (GSK) | 10.2 | $5.3M | 150k | 35.14 | |
| Gilead Sciences (GILD) | 10.1 | $5.2M | 61k | 85.85 | |
| CVS Caremark Corporation (CVS) | 9.4 | $4.8M | 52k | 93.19 | |
| Bristol Myers Squibb (BMY) | 9.0 | $4.7M | 65k | 71.95 | |
| Kempharm Com New (ZVRA) | 2.9 | $1.5M | 330k | 4.59 | |
| Aurinia Pharmaceuticals (AUPH) | 1.9 | $994k | 230k | 4.32 | |
| UnitedHealth (UNH) | 0.4 | $201k | 379.00 | 530.18 | |
| Abbvie (ABBV) | 0.3 | $131k | 811.00 | 161.61 | |
| Merck & Co (MRK) | 0.2 | $123k | 1.1k | 110.95 | |
| Eli Lilly & Co. (LLY) | 0.2 | $123k | 335.00 | 365.84 | |
| Thermo Fisher Scientific (TMO) | 0.2 | $121k | 220.00 | 550.69 | |
| Regeneron Pharmaceuticals (REGN) | 0.1 | $67k | 93.00 | 721.49 | |
| Pfizer (PFE) | 0.1 | $63k | 1.2k | 51.24 | |
| Vertex Pharmaceuticals Incorporated (VRTX) | 0.1 | $62k | 216.00 | 288.78 | |
| AmerisourceBergen (COR) | 0.1 | $51k | 309.00 | 165.71 | |
| Boston Scientific Corporation (BSX) | 0.1 | $49k | 1.1k | 46.27 | |
| Stryker Corporation (SYK) | 0.1 | $48k | 198.00 | 244.49 | |
| Iqvia Holdings (IQV) | 0.1 | $44k | 215.00 | 204.89 | |
| BioMarin Pharmaceutical (BMRN) | 0.1 | $43k | 414.00 | 103.49 | |
| Dex (DXCM) | 0.1 | $34k | 299.00 | 113.24 | |
| Moderna (MRNA) | 0.1 | $34k | 187.00 | 179.62 | |
| Royalty Pharma Shs Class A (RPRX) | 0.1 | $31k | 791.00 | 39.52 | |
| Edwards Lifesciences (EW) | 0.1 | $27k | 356.00 | 74.61 | |
| Masimo Corporation (MASI) | 0.0 | $23k | 152.00 | 147.95 | |
| Neurocrine Biosciences (NBIX) | 0.0 | $22k | 186.00 | 119.44 | |
| Option Care Health Com New (OPCH) | 0.0 | $22k | 736.00 | 30.09 | |
| Alnylam Pharmaceuticals (ALNY) | 0.0 | $22k | 93.00 | 237.65 | |
| Cytokinetics Com New (CYTK) | 0.0 | $20k | 440.00 | 45.82 | |
| Doximity Cl A (DOCS) | 0.0 | $16k | 462.00 | 33.56 | |
| Intra Cellular Therapies (ITCI) | 0.0 | $16k | 292.00 | 52.92 | |
| Prometheus Biosciences | 0.0 | $13k | 122.00 | 110.00 | |
| EXACT Sciences Corporation (EXAS) | 0.0 | $13k | 268.00 | 49.51 | |
| Inspire Med Sys (INSP) | 0.0 | $13k | 52.00 | 251.88 | |
| Krystal Biotech (KRYS) | 0.0 | $11k | 139.00 | 79.22 | |
| Akero Therapeutics (AKRO) | 0.0 | $9.1k | 166.00 | 54.80 | |
| Outset Med (OM) | 0.0 | $8.9k | 344.00 | 25.82 | |
| Bellus Health Com New | 0.0 | $8.8k | 1.1k | 8.22 | |
| Prothena Corp SHS (PRTA) | 0.0 | $7.9k | 131.00 | 60.25 | |
| Maravai Lifesciences Hldgs I Com Cl A (MRVI) | 0.0 | $6.8k | 475.00 | 14.31 | |
| Amicus Therapeutics (FOLD) | 0.0 | $6.8k | 554.00 | 12.21 | |
| Bridgebio Pharma (BBIO) | 0.0 | $6.8k | 887.00 | 7.62 | |
| Bicycle Therapeutics Sponsored Adr (BCYC) | 0.0 | $6.7k | 226.00 | 29.60 | |
| Karuna Therapeutics Ord | 0.0 | $6.7k | 34.00 | 196.50 | |
| Shockwave Med (SWAV) | 0.0 | $6.6k | 32.00 | 205.62 | |
| ImmunoGen | 0.0 | $6.4k | 1.3k | 4.96 | |
| Poseida Therapeutics I (PSTX) | 0.0 | $5.7k | 1.1k | 5.30 | |
| Merus N V (MRUS) | 0.0 | $4.4k | 286.00 | 15.47 | |
| Arcellx Common Stock (ACLX) | 0.0 | $4.4k | 142.00 | 30.98 | |
| Denali Therapeutics (DNLI) | 0.0 | $4.4k | 158.00 | 27.81 |
